Cao Li, Shen Meihong, Yu Hong, Lv Hongyan, A Gula
School of Acupuncture-Moxibustion and Tuina & School of Health Preservation and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, China.
School of Nursing, Baotou Medical College.
Zhongguo Zhen Jiu. 2024 Jul 12;44(7):787-91. doi: 10.13703/j.0255-2930.20230816-k0001.
To observe the clinical effect and safety of the warm acupuncture of Mongolian medicine in treatment of insomnia in the elderly, and to explore its underlying brain-gut peptide mechanism.
Sixty elderly patients with insomnia were randomly divided into a warm acupuncture group and a western medication group, 30 cases in each group. In the warm acupuncture group, the warm acupuncture of Mongolian medicine was operated at Dinghuixue (at the center of the vertex, the crossing site of the anterior midline and the line connected the upper edges of two ear apexes), Heyixue (at the depression of the spinous process of the 7th cervical vertebra) or Xinxue (at the depression of the spinous process of the 6th thoracic vertebra) in each treatment. Only one of the above points was selected and stimulated for 20 min one treatment and the three points were used alternatively. The treatment was given once every day or every other day, 3 times a week, and for a total of 3 weeks. In the western medication group, estazolam tablets were administered orally, once a day, 1 mg before bedtime, consecutively for 3 weeks. Before and after treatment, as well as in 1-month follow-up visit after the treatment completion, the scores of the Pittsburgh sleep quality index (PSQI) and the insomnia severity index (ISI) were observed in the two groups. The serum brain-related peptide markers (substance P [SP], neuropeptide Y [NPY], 5-hydroxytryptamine 1A [5-HT1A] and 5-hydroxytryptamine 2A [5-HT2A]) were measured before and after treatment, and the clinical efficacy and safety was evaluated in the two groups.
After treatment and in follow-up, the scores of sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbance and daytime dysfunction, as well as the total scores of PSQI, and ISI scores were all reduced in the two groups (<0.05, <0.01); and the scores in the warm acupuncture group were lower than those of the western medication group (<0.05, <0.01). After treatment, the levels of serum SP and 5-HT2A were decreased (<0.01) and the levels of serum NPY and 5-HT1A were increased (<0.01) when compared with those before treatment in the two groups. The levels of serum SP and 5-HT2A in the warm acupuncture group were lower than those of the western medication group (<0.05), and the levels of serum NPY and 5-HT1A were higher than those of the western medication group (<0.05). After treatment, the total effective rate was 93.3% (28/30) in the warm acupuncture group, which was higher than 83.3% (25/30) of the western medication group (<0.05). No serious adverse reactions were found in the two groups.
Warm acupuncture of Mongolian medicine can effectively improve the sleep quality of the elderly patients with insomnia, and its mechanism may be related to the regulation of the levels of serum SP, NPY, 5-HT1A and 5-HT2A.
观察蒙医温针治疗老年失眠症的临床疗效及安全性,并探讨其潜在的脑肠肽机制。
将60例老年失眠患者随机分为温针组和西药组,每组30例。温针组每次治疗选取顶会穴(位于头顶正中,前正中线与两耳尖上缘连线的交点处)、和一穴(位于第7颈椎棘突下凹陷处)或心穴(位于第6胸椎棘突下凹陷处)中的一个穴位进行蒙医温针治疗,每次刺激20分钟,三个穴位交替使用。治疗每日或隔日1次,每周3次,共3周。西药组口服艾司唑仑片,每日1次,睡前1mg,连续服用3周。治疗前后及治疗结束后1个月随访时,观察两组匹兹堡睡眠质量指数(PSQI)和失眠严重程度指数(ISI)评分。检测治疗前后血清脑相关肽标志物(P物质[SP]、神经肽Y[NPY]、5-羟色胺1A[5-HT1A]和5-羟色胺2A[5-HT2A]),并评价两组的临床疗效及安全性。
治疗后及随访时,两组睡眠质量、入睡时间、睡眠时间、睡眠效率、睡眠障碍及日间功能障碍评分以及PSQI总分、ISI评分均降低(<0.05,<0.01);且温针组评分低于西药组(<0.05,<0.01)。治疗后,两组血清SP和5-HT2A水平降低(<0.01),血清NPY和5-HT1A水平升高(<0.01)。温针组血清SP和5-HT2A水平低于西药组(<0.05),血清NPY和5-HT1A水平高于西药组(<0.05)。治疗后,温针组总有效率为93.3%(28/30),高于西药组的83.3%(25/30)(<0.05)。两组均未发现严重不良反应。
蒙医温针可有效改善老年失眠患者的睡眠质量,其机制可能与调节血清SP、NPY、5-HT1A和5-HT2A水平有关。